Association Between UCP3 Gene Polymorphisms and Nonalcoholic Fatty Liver Disease in Chinese Children

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2013 Oct 15

PMID 24124336

Citations 13

Authors

Yan-Ping Xu

Li Liang

Chun-Lin Wang

Jun-Fen Fu

Pei-Ning Liu

Lan-Qiu Lv

Yi-Min Zhu

Affiliations

Soon will be listed here.

Abstract

Aim: To confirm the hypothesis that polymorphisms of the uncoupling protein 3 (UCP3) gene are associated with the occurrence of nonalcoholic fatty liver disease (NAFLD).

Methods: A total of 250 NAFLD patients (147 males and 103 females) and 200 healthy individuals who served as controls (control, 109 males and 91 females), aged between 6 and 16 years were enrolled in this study. The four non-synonymous single nucleotide polymorphisms (SNPs) in the UCP3 gene polymorphisms of rs1726745, rs3781907, rs11235972 and rs1800849, were genotyped using MassArray. Body mass index (BMI), waist and hip circumference, blood pressure (BP), fasting blood glucose (FBG), insulin and lipid profiles were measured and B-ultrasound examination was performed in all subjects.

Results: NAFLD patients showed risk factors for metabolic syndrome: elevated BMI, waist-to-hip ratio, BP, FBG, homeostasis model assessment-estimated insulin resistance, total triglyceride, total cholesterol and low-density lipoprotein-cholesterol, while decreased high-density lipoprotein-cholesterol level compared with the control group. The GG genotype distributions of rs11235972 in the NAFLD group differed significantly from that in the control group. We found that waist circumference between CC (58.76 ± 6.45 cm) and CT+TT (57.00 ± 5.59 cm), and hip circumference between CC (71.28 ± 7.84 cm) and CT+TT genotypes (69.06 ± 7.75 cm) were significantly different with and without rs1800849 variation (P < 0.05).

Conclusion: A higher prevalence of rs11235972 GG genotype was observed in the NAFLD group compared with the control group. No differences were observed for the other SNPs. However, there was a significant difference in body height in addition to waist and hip circumference between the CC (mutant type group) and CT+TT group with and without rs1800849 variation.

Citing Articles

Relationships between Uncoupling Protein Genes , and and Irisin Levels in Residents of the Coldest Region of Siberia.

Nikanorova A, Barashkov N, Pshennikova V, Gotovtsev N, Romanov G, Solovyev A Genes (Basel). 2022; 13(9).

PMID: 36140780 PMC: 9498418. DOI: 10.3390/genes13091612.

Sex-Dependent Effects of Eicosapentaenoic Acid on Hepatic Steatosis in UCP1 Knockout Mice.

Albracht-Schulte K, Wilson S, Johnson P, Pahlavani M, Ramalingam L, Goonapienuwala B Biomedicines. 2021; 9(11).

PMID: 34829779 PMC: 8615653. DOI: 10.3390/biomedicines9111549.

The Liver in Children With Metabolic Syndrome.

DAdamo E, Castorani V, Nobili V Front Endocrinol (Lausanne). 2019; 10:514.

PMID: 31428049 PMC: 6687849. DOI: 10.3389/fendo.2019.00514.

Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation.

Yang J, Fernandez-Galilea M, Martinez-Fernandez L, Gonzalez-Muniesa P, Perez-Chavez A, Martinez J Nutrients. 2019; 11(4).

PMID: 31003450 PMC: 6521137. DOI: 10.3390/nu11040872.

A small supernumerary marker chromosome resulting in mosaic partial tetrasomy 4q26-q31.21 in a foetus with multiple congenital malformations.

Zhang Z, Qi W, Liu C, Yin S, Zhao Y, Li-Ling J J Genet. 2019; 98.

PMID: 30945692

References

Schrauwen P, Xia J, Walder K, Snitker S, Ravussin E . A novel polymorphism in the proximal UCP3 promoter region: effect on skeletal muscle UCP3 mRNA expression and obesity in male non-diabetic Pima Indians. Int J Obes Relat Metab Disord. 2000; 23(12):1242-5. DOI: 10.1038/sj.ijo.0801057. View

Hamada T, Kotani K, Fujiwara S, Sano Y, Domichi M, Tsuzaki K . The common -55 C/T polymorphism in the promoter region of the uncoupling protein 3 gene reduces prevalence of obesity and elevates serum high-density lipoprotein cholesterol levels in the general Japanese population. Metabolism. 2008; 57(3):410-5. DOI: 10.1016/j.metabol.2007.10.019. View

Hamaguchi M, Takeda N, Kojima T, Ohbora A, Kato T, Sarui H . Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome. World J Gastroenterol. 2012; 18(13):1508-16. PMC: 3319947. DOI: 10.3748/wjg.v18.i13.1508. View

Tominaga K, Kurata J, Chen Y, Fujimoto E, Miyagawa S, Abe I . Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci. 1995; 40(9):2002-9. DOI: 10.1007/BF02208670. View

Yoon Y, Park B, Cha M, Kim K, Cheong H, Choi Y . Effects of genetic polymorphisms of UCP2 and UCP3 on very low calorie diet-induced body fat reduction in Korean female subjects. Biochem Biophys Res Commun. 2007; 359(3):451-6. DOI: 10.1016/j.bbrc.2007.05.110. View

Jimba S, Nakagami T, Takahashi M, Wakamatsu T, Hirota Y, Iwamoto Y . Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med. 2005; 22(9):1141-5. DOI: 10.1111/j.1464-5491.2005.01582.x. View

Burgert T, Taksali S, Dziura J, Goodman T, Yeckel C, Papademetris X . Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab. 2006; 91(11):4287-94. DOI: 10.1210/jc.2006-1010. View

Amarapurkar D, Hashimoto E, Lesmana L, Sollano J, Chen P, Goh K . How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?. J Gastroenterol Hepatol. 2007; 22(6):788-93. DOI: 10.1111/j.1440-1746.2007.05042.x. View

de Luis D, Aller R, Izaola O, Gonzalez Sagrado M, Conde R, Castrillon J . Lack of association of -55CT polymorphism of UCP3 gene with fat distribution in obese patients. Ann Nutr Metab. 2007; 51(4):374-8. DOI: 10.1159/000107685. View

10.

Radu C, Grigorescu M, Crisan D, Lupsor M, Constantin D, Dina L . Prevalence and associated risk factors of non-alcoholic fatty liver disease in hospitalized patients. J Gastrointestin Liver Dis. 2008; 17(3):255-60. View

11.

Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T . The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol. 2007; 102(12):2708-15. DOI: 10.1111/j.1572-0241.2007.01526.x. View

12.

Liu Y, Liu P, Long J, Lu Y, Elze L, Recker R . Linkage and association analyses of the UCP3 gene with obesity phenotypes in Caucasian families. Physiol Genomics. 2005; 22(2):197-203. DOI: 10.1152/physiolgenomics.00031.2005. View

13.

Park H, Han J, Choi K, Kim S . Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Am J Clin Nutr. 2005; 82(5):1046-51. DOI: 10.1093/ajcn/82.5.1046. View

14.

Strauss R, Barlow S, Dietz W . Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr. 2000; 136(6):727-33. View

15.

Herrmann S, Wang J, Staessen J, Kertmen E, Schmidt-Petersen K, Zidek W . Uncoupling protein 1 and 3 polymorphisms are associated with waist-to-hip ratio. J Mol Med (Berl). 2003; 81(5):327-32. DOI: 10.1007/s00109-003-0431-1. View

16.

Iacobellis A, Marcellini M, Andriulli A, Perri F, Leandro G, DeVito R . Non invasive evaluation of liver fibrosis in paediatric patients with nonalcoholic steatohepatitis. World J Gastroenterol. 2007; 12(48):7821-5. PMC: 4087549. DOI: 10.3748/wjg.v12.i48.7821. View

17.

Schwimmer J, Deutsch R, Kahen T, Lavine J, Stanley C, Behling C . Prevalence of fatty liver in children and adolescents. Pediatrics. 2006; 118(4):1388-93. DOI: 10.1542/peds.2006-1212. View

18.

Barshop N, Sirlin C, Schwimmer J, Lavine J . Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2008; 28(1):13-24. DOI: 10.1111/j.1365-2036.2008.03703.x. View

19.

Sundaram S, Zeitler P, Nadeau K . The metabolic syndrome and nonalcoholic fatty liver disease in children. Curr Opin Pediatr. 2009; 21(4):529-35. PMC: 3073840. DOI: 10.1097/MOP.0b013e32832cb16f. View

20.

van der Poorten D, Milner K, Hui J, Hodge A, Trenell M, Kench J . Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology. 2008; 48(2):449-57. DOI: 10.1002/hep.22350. View